Antiviral Repurposing

Antiviral Repurposing is a natural product repurposing strategy that involves the identification and redirection of existing bioactive compounds, originally derived from natural sources and intended for non-antiviral purposes, toward the inhibition or treatment of viral infections through mechanisms such as viral entry blockade, replication interference, or host immune modulation.

71

Publications

6.3K

Citations

562

Authors

230

Institutions

Publications per year

2017–2026

65

Authors

562

  1. KB
    Khushboo Bafna

    Rensselaer Polytechnic Institute, United States

    2 publications · 103 citations

    2

    h-index

  2. NB
    Nadia Brügger

    Ono Pharmaceutical (United States), United States

    2 publications · 38 citations

    2

    h-index

  3. AO
    Andrew Owen

    University of Liverpool, United Kingdom

    2 publications · 50 citations

    2

    h-index

  4. XY
    Xin Yin

    Harbin Veterinary Research Institute, China

    2 publications · 917 citations

    2

    h-index

  5. DK
    Dennis K. Ninaber

    Leiden University Medical Center, Netherlands

    2 publications · 146 citations

    2

    h-index

1–5 of 562

Venues

  1. Journal of Biomolecular Structure and Dynamics

    4 publications · 121 citations

    4

    h-index

  2. medRxiv

    Repository · 3 publications · 50 citations

    3

    h-index

  3. International Journal of Molecular Sciences

    IJMS · 3 publications · 46 citations

    3

    h-index

  4. ChemRxiv

    Repository · 3 publications · 114 citations

    3

    h-index

  5. PubMed

    Repository · 2 publications · 75 citations

    2

    h-index

1–5